SAN
FRANCISCO, Jan. 3, 2024 /PRNewswire/ -- Nektar
(Nasdaq: NKTR) management is scheduled to present at the upcoming
42nd Annual J.P. Morgan Healthcare Conference in
San Francisco on Wednesday, January 10, 2024 at 5:15 p.m.
Pacific Time. The presentation and Q&A session will be
accessible via a Webcast through a link posted on the Investor
Events Calendar section of the Nektar website:
https://ir.nektar.com/events-and-presentations/events. This webcast
will be available for replay until February
9, 2024.
About Nektar
Nektar Therapeutics is a biopharmaceutical company with a
robust, wholly owned R&D pipeline of investigational medicines
in oncology and immunology as well as a portfolio of approved
partnered medicines. Nektar is headquartered in San Francisco, California, with additional
operations in Huntsville, Alabama.
Further information about the company and its drug development
programs and capabilities may be found online at
http://www.nektar.com.
Contact:
For Investors:
Vivian
Wu of Nektar Therapeutics
628-895-0661
For Media:
David Rosen
of Argot Partners
(212) 600-1902
david.rosen@argotpartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nektar-management-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-in-san-francisco-ca-302025739.html
SOURCE Nektar Therapeutics